髓源性抑制细胞的转录调控
Transcriptional regulation of myeloid-derived suppressor cells.
作者信息
Condamine Thomas, Mastio Jérôme, Gabrilovich Dmitry I
机构信息
The Wistar Institute, Philadelphia, Pennsylvania, USA.
The Wistar Institute, Philadelphia, Pennsylvania, USA
出版信息
J Leukoc Biol. 2015 Dec;98(6):913-22. doi: 10.1189/jlb.4RI0515-204R. Epub 2015 Sep 3.
Myeloid-derived suppressor cells are a heterogeneous group of pathologically activated immature cells that play a major role in the negative regulation of the immune response in cancer, autoimmunity, many chronic infections, and inflammatory conditions, as well as in the regulation of tumor angiogenesis, tumor cell invasion, and metastases. Accumulation of myeloid-derived suppressor cells is governed by a network of transcriptional regulators that could be combined into 2 partially overlapping groups: factors promoting myelopoiesis and preventing differentiation of mature myeloid cells and factors promoting pathologic activation of myeloid-derived suppressor cells. In this review, we discuss the specific nature of these factors and their impact on myeloid-derived suppressor cell development.
髓源性抑制细胞是一组异质性的病理激活未成熟细胞,在癌症、自身免疫性疾病、多种慢性感染和炎症性疾病中免疫反应的负调节以及肿瘤血管生成、肿瘤细胞侵袭和转移的调节中起主要作用。髓源性抑制细胞的积累受转录调节因子网络的控制,这些转录调节因子可分为2个部分重叠的组:促进髓系造血并阻止成熟髓系细胞分化的因子,以及促进髓源性抑制细胞病理激活的因子。在本综述中,我们讨论了这些因子的具体性质及其对髓源性抑制细胞发育的影响。
相似文献
J Leukoc Biol. 2015-12
Annu Rev Med. 2015
Trends Immunol. 2015-4
Biochemistry (Mosc). 2016-11
Eur J Immunol. 2010-11
Ann N Y Acad Sci. 2014-6
Innate Immun. 2013-6-11
引用本文的文献
Pharmaceuticals (Basel). 2025-6-29
ILIVER. 2022-7-20
J Clin Cell Immunol. 2025
本文引用的文献
Cell Death Dis. 2015-3-26
Int J Hematol. 2015-4
Trends Cell Biol. 2015-5
Proc Natl Acad Sci U S A. 2015-2-10
J Clin Invest. 2015-2